Saturday, October 31, 2026

Unlocking Weight Loss: How Celltrion’s New CT-G32 and Oral Multi-Action Drug Will Change the Game

Celltrion aims to lead the obesity treatment market with innovative drugs, enhancing efficacy and patient convenience through dual approaches.

Is South Korea’s Unification Minister a Threat to U.S. Relations? Analysis of Controversial Remarks

Song Eon-seok demands the dismissal of Unification Minister Chung over controversial remarks, urging transparency and reforms in real estate policies.

Landing Giants: How Aircraft Tires Handle Extreme Conditions

Known as a jumbo jet, Boeing's B747...

Health

Unlock Your Health: Discover the New AI-Powered BioAge and Health Coach Services from DaNaA Data

Daewoo Group's AI health data firm, DaNaA Data, launched a service analyzing biological age, disease risk, and health check results.

How the New Medical School in Namwon Can Transform Regional Healthcare: Insights from Lawmaker Park Ji-won

Defining school locations alone won't solve local healthcare issues; deeper strategies are needed for effective solutions.

Ardens Lifescience Triumphs: How a Korean Startup Won 175,000 USD at MedTech Innovator APAC 2026

Adenz Life Sciences wins a global medical device competition, earning a prize of 175,000 USD.

Unlocking the Future of Healthcare: Daewoong’s AI-Powered Smart Hospital at AI EXPO MARS 2026

Daewoong Pharmaceutical introduces an AI-based smart hospital model for monitoring, diagnosis, testing, and rehabilitation.

10 Years of Excellence: Seoul’s APLAR Center Hosts International Rheumatology Training for Young Specialists

Seoul St. Mary's Hospital's Rheumatology Center held an international training program for foreign experts on October 27 and 26.
Latest

Why Galux is the Only Korean Bio-Tech Company on Forbes’ 2026 Asia’s 100 Most Promising Companies List?

Galaxy has been named one of Forbes' '100 Asian Companies to Watch in 2026', the only bio-healthcare firm among 9 Korean selections.

Revolutionizing Obesity Treatment: Hanmi Pharmaceutical’s Digital Fusion Drug EPPE Launching in 2026

Hanmi Pharmaceutical is developing digital therapeutics by combining obesity treatment 'Efe' with digital technology.

Revolutionary Cancer Drug Penitrium Shows Promise in Restoring Chemotherapy Effectiveness

Pennitrium Bioscience has confirmed the potential of a new drug candidate to enhance the effectiveness of existing cancer treatments.

FDA Designates BAL0891 as Rare Drug for Acute Myeloid Leukemia: What This Means for Cancer Treatment in Asia

Shinlajen's cancer drug candidate 'BAL0891' receives rare disease designation for acute myeloid leukemia from the FDA.

Revolutionizing Cardiovascular Care: How Quantum Computing is Transforming Blood Flow Analysis in 2026

Seoul St. Mary's Hospital develops technology using quantum computing to analyze blood flow in cardiovascular patients quickly and precisely.

Can Activating SIRT1 Protect Your Retinal Health? Discover the Latest Research

Research reveals that micro and nano plastics can impair retinal cell antioxidant functions and accelerate cell aging, with potential protective targets.

New Leadership in Medical Devices: Prof. Koo Appointed as Chair of Korea’s Medical Device Committee

Professor Koo Seung-wook has been appointed as the private chair of the Medical Device Committee until June 28, 2028.

Unlocking Biosimilar Success: Key Insights from the WHO Workshop in Asia

The Korean Ministry of Food and Drug Safety collaborates with WHO to unify biosimilar review standards in the Asia-Pacific region.

Celltrion’s CT-P51: Will This Keytruda Biosimilar Disrupt the 44 Billion USD Cancer Drug Market?

Celltrion has applied for approval of its biosimilar CT-P51 for the global blockbuster immuno-oncology drug Keytruda (pembrolizumab).

Unlock Radiant Skin: How Amorepacific’s Hybrid Skincare Combines LED Masks and Injectables

Amorepacific confirms skin improvement and recovery effects through hybrid skincare research combining dermatological treatments and home care devices.

How EC-IC Bypass Surgery Training is Revolutionizing Neurosurgical Techniques in Asia

CGBIO enhances training for complex neurosurgical procedures, utilizing cadaver simulations to improve skills and clinical application.

Rheumatoid Arthritis Breakthrough: How Oral Pills Could Replace Injections

Researchers from Catholic University of Korea are developing an oral form of rheumatoid arthritis injections with a U.S. institute.

How AI is Revolutionizing Custom Cancer Vaccines: Insights from Neogen Logic’s 2027 IND Plans

Moderna and Merck's personalized cancer vaccine shows positive Phase 3 results, boosting interest in AI-based vaccine development in Korea.

KIO-301: The Innovative Treatment for Retinitis Pigmentosa – What You Need to Know

Chong Kun Dang partners with Kiora Pharmaceuticals to develop and commercialize a new retinal disease treatment in South Korea.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.